9:00am - 5:00pm

Office Hours Mon. - Fri.


Call Us For Free Consultation



Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

Estimated reading time: < 1 min


Malignant Mesothelioma

Estimated Enrollment: 60

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Primary Purpose: Treatment

Study ID Numbers: CDR0000564058|COL-ALIMESO|INCA-RECF0441|COL-2006-04

Study First Received: October 5, 2007

Last Updated: May 14, 2011

Estimated Primary Completion Date: May 2011

Primary Outcome Measures:

Individual dosage-adapted protocol|Relationship between pharmacokinetic and pharmacodynamic parameters|Pharmacokinetics|Pharmacogenetic variations (MTHFR, TS, GSTpi, ERCC1, XPD)

Sponsors and Collaborators:

Centre Oscar Lambret|National Cancer Institute (NCI)

Result Received: No Study Results Posted

Website Link: https://ClinicalTrials.gov/show/NCT00541073

Was this article helpful?
Views: 46